[This corrects the article DOI: 10.1155/2018/6513049.].
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5976930 | PMC |
| http://dx.doi.org/10.1155/2018/5327589 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Correction: A Single-Center Pilot Study of Therapeutic Apheresis in Patients with Severe Post-COVID Syndrome.
Horm Metab Res
December 2024
Apherese-Zentrum am Kortumpark, Bochum, Germany.
Author Correction: Intestinal TM6SF2 protects against metabolic dysfunction-associated steatohepatitis through the gut-liver axis.
Nat Metab
January 2025
Department of Medicine and Therapeutics, Institute of Digestive Disease, State Key Laboratory of Digestive Disease, Li Ka Shing Institute of Health Sciences, The Chinese University of Hong Kong, Hong Kong SAR, China.
Correction to: Binding of carbon nanotube to BMP receptor 2 enhances cell differentiation and inhibits apoptosis via regulating bHLH transcription factors.
Cell Death Dis
January 2025
Department of Chemical Biology and Therapeutics, St. Jude Children's Research Hospital, Memphis, TN, USA.
Corrigendum: Efficacy of Oroxylin A in ameliorating renal fibrosis with emphasis on Sirt1 activation and TGF-β/Smad3 pathway modulation.
Front Pharmacol
January 2025
School of Chemistry and Chemical Engineering, Qilu Normal University, Jinan, China.
[This corrects the article DOI: 10.3389/fphar.2024.
View Article and Find Full Text PDFCorrigendum: Cipaglucosidase alfa plus miglustat: linking mechanism of action to clinical outcomes in late-onset Pompe disease.
Front Neurol
January 2025
Department of Neurology, University of California, Irvine, Irvine, CA, United States.
[This corrects the article DOI: 10.3389/fneur.2024.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!